Tetratherix (ASX:TTX) is pivoting into one interesting class of biotech product well outside its existing focus on skin ...

Explore the latest colorectal cancer treatment advances, from precision oncology and immunotherapy to ADCs, bispecifics, and ...

Aurion Biotech has appointed Dr. Marjan Farid of the University of California-Irvine’s Gavin Herbert Eye Institute as chair of its medical advisory board. (PRESS RELEASE) SEATTLE, WA; CAMBRIDGE, MA; ...

President Donald Trump is visiting Ohio and Kentucky as he tries to steady voters' concerns about the economy and to derail the reelection bid of a Republican rival.

Rare disease biotech stocks pop on the news that Vinay Prasad, the FDA’s chief biologics regulator, will depart the FDA at the end of April; Sen. Ron Johnson launches an investigation into recent rare ...

Aurion Biotech today named Dr. Marjan Farid, Director of Cornea, Cataract, and Refractive Surgery and a Clinical Professor at ...

LOS CABOS, BAJA CALIFORNIA SUR, Mexico, March 11, 2026 /PRNewswire/ -- Physicians and scientists from Longevity Medical Institute(R) have published new peer-reviewed research examining the therapeutic ...

Meet 5 hot biotechs in Arizona, from Phoenix to Tucson, that have raised significant funding over the past decade.

This will be Prasad’s second exit from the FDA during the current Trump administration. In July, he resigned amid his controversial handling of a gene therapy treatment for Duchenne muscular dystrophy ...

After a heart attack, the heart struggles to recoup and maintain energy. One-third of patients develop heart failure as a ...

UniQure's stock (QURE) closed 26% higher on Monday. Late Friday, the FDA told the Wall Street Journal that Vinay Prasad plans to leave the agency next month. He is the director of the FDA's Center for ...

Rapid advances in artificial intelligence, machine learning, and data-driven computational modeling have opened unprecedented opportunities to transform ...